相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments
Luke A. McGuinness et al.
RESEARCH SYNTHESIS METHODS (2021)
Industry payments to Australian medical oncologists and clinical haematologists: a cross-sectional analysis of publicly available disclosures
Adrian M. J. Pokorny et al.
INTERNAL MEDICINE JOURNAL (2021)
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? A Systematic Review
Aaron P. Mitchell et al.
ANNALS OF INTERNAL MEDICINE (2021)
Financial payments made by pharmaceutical companies to the authors of Japanese hematology clinical practice guidelines between 2016 and 2017
Kayo Harada et al.
HEALTH POLICY (2021)
Association between Opioid Prescribing in Medicare and Pharmaceutical Company Gifts by Physician Specialty
Mara A. G. Hollander et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Financial ties between leaders of influential US professional medical associations and industry: cross sectional study
Ray Moynihan et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Nonresearch Pharmaceutical Industry Payments to Oncology Physician Editors
Waqas Haque et al.
ONCOLOGIST (2020)
The Impact Of Academic Medical Center Policies Restricting Direct-To-Physician Marketing On Opioid Prescribing
Matthew D. Eisenberg et al.
HEALTH AFFAIRS (2020)
Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology
Aaron P. Mitchell et al.
ONCOLOGIST (2019)
Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study
Joel Lexchin
BMJ OPEN (2019)
Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study
Behrad Behdarvand et al.
BMJ OPEN (2019)
Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis
Akihiko Ozaki et al.
BMJ OPEN (2019)
Association between physician characteristics and payments from industry in 2015-2017: observational study
Kosuke Inoue et al.
BMJ OPEN (2019)
Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan
Hiroaki Saito et al.
JAMA NETWORK OPEN (2019)
Conflict of interest among Italian medical oncologists: a national survey
Andrea DeCensi et al.
BMJ OPEN (2018)
Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries
Aaron P. Mitchell et al.
JAMA INTERNAL MEDICINE (2018)
Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing
Scott E. Hadland et al.
JAMA INTERNAL MEDICINE (2018)
Financial Conflicts of Interest Among Oncologist Authors of Reports of Clinical Drug Trials
Cole Wayant et al.
JAMA ONCOLOGY (2018)
Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing
Mark A. Zezza et al.
PLOS ONE (2018)
Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia
Yeh Chen Lee et al.
INTERNAL MEDICINE JOURNAL (2017)
Discordance of conflict of interest self-disclosure and the Centers of Medicare and Medicaid Services
Deepa V. Cherla et al.
JOURNAL OF SURGICAL RESEARCH (2017)
Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review
Freek Fickweiler et al.
BMJ OPEN (2017)
A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia
Alice Fabbri et al.
BMJ OPEN (2017)
Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective - observational study
Jessica J. Liu et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective - observational study
Jessica J. Liu et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Financial Conflicts of Interest Among Hematologist-Oncologists on Twitter
Derrick L. Tao et al.
JAMA INTERNAL MEDICINE (2017)
Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis
Hneine Brax et al.
PLOS ONE (2017)
The Lack of a Relationship Between Physician Payments From Drug Manufacturers and Medicare Claims for Abiraterone and Enzalutamide
Jathin Bandari et al.
CANCER (2017)
Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: a systematic review
Tamara Lotfi et al.
BMC HEALTH SERVICES RESEARCH (2016)
PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
Jessie McGowan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Distribution and Patterns of Industry-Related Payments to Oncologists in 2014
Deborah C. Marshall et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Distribution and Patterns of Industry-Related Payments to Oncologists in 2014
Deborah C. Marshall et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration
Ariadna Tibau et al.
JAMA ONCOLOGY (2016)
Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors
Aaron P. Mitchell et al.
JAMA ONCOLOGY (2016)
Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs
Roy H. Perlis et al.
PLOS ONE (2016)
Nothing to Declare: Mandatory and Voluntary Disclosure Leads Advisors to Avoid Conflicts of Interest
Sunita Sah et al.
PSYCHOLOGICAL SCIENCE (2014)
Show Us the Money: Lessons in Transparency from State Pharmaceutical Marketing Disclosure Laws
Susan Chimonas et al.
HEALTH SERVICES RESEARCH (2010)
Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review
Geoffrey K. Spurling et al.
PLOS MEDICINE (2010)
Frequency, Nature, Effects, and Correlates of Conflicts of Interest in Published Clinical Cancer Research
Reshma Jagsi et al.
CANCER (2009)
Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
Jane Robertson et al.
PLOS MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Physicians and the pharmaceutical industry - Is a gift ever just a gift?
A Wazana
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
